Infimer Stock Shares Outstanding
INFR Stock | ILA 60.40 0.00 0.00% |
Infimer fundamentals help investors to digest information that contributes to Infimer's financial success or failures. It also enables traders to predict the movement of Infimer Stock. The fundamental analysis module provides a way to measure Infimer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Infimer stock.
Infimer |
Infimer Company Shares Outstanding Analysis
Infimer's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Infimer Shares Outstanding | 1.06 M |
Most of Infimer's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Infimer is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
Based on the latest financial disclosure, Infimer has 1.06 M of shares currently outstending. This is 99.27% lower than that of the Chemicals sector and 99.1% lower than that of the Materials industry. The shares outstanding for all Israel stocks is 99.81% higher than that of the company.
Infimer Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Infimer's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Infimer could also be used in its relative valuation, which is a method of valuing Infimer by comparing valuation metrics of similar companies.Infimer is currently under evaluation in shares outstanding category among related companies.
Infimer Fundamentals
Return On Asset | -0.33 | |||
Operating Margin | (9.80) % | |||
Current Valuation | 25.15 M | |||
Shares Outstanding | 1.06 M | |||
Shares Owned By Insiders | 14.32 % | |||
Shares Owned By Institutions | 10.35 % | |||
Price To Earning | (867.76) X | |||
Price To Sales | 4,759 X | |||
Revenue | 378 K | |||
Gross Profit | (899 K) | |||
EBITDA | (3.15 M) | |||
Net Income | (7.99 M) | |||
Cash And Equivalents | 14 K | |||
Cash Per Share | 0.01 X | |||
Total Debt | 289 K | |||
Current Ratio | 0.02 X | |||
Book Value Per Share | (5.82) X | |||
Cash Flow From Operations | (1.59 M) | |||
Earnings Per Share | (5.30) X | |||
Number Of Employees | 23.7 K | |||
Beta | 1.52 | |||
Market Capitalization | 17.99 M | |||
Z Score | 37.2 | |||
Last Dividend Paid | 589.96 |
About Infimer Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Infimer's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Infimer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Infimer based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Infimer. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Infimer Stock analysis
When running Infimer's price analysis, check to measure Infimer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infimer is operating at the current time. Most of Infimer's value examination focuses on studying past and present price action to predict the probability of Infimer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infimer's price. Additionally, you may evaluate how the addition of Infimer to your portfolios can decrease your overall portfolio volatility.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements |